Monograph Details
|
|
Eye Disorders
> Ocular infections
|
|
VIROPTIC |
| Manufacturer |
|
King Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Antiviral. |
| Generic Name |
|
Trifluridine 1%; oph. soln; contains thimerosal. |
| Indications |
|
Primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex types 1 and 2. |
| Adults and Children |
|
<6yrs: Not recommended. Do not exceed recommended dose. ≥6yrs: 1 drop every 2 hrs while awake; max 9 drops/day. After reepithelialization, 1 drop every 4 hrs for 7 days (at least 5 drops/day); max 21 days therapy. Reevaluate if no improvement in 7 days or incomplete reepithelialization in 14 days. |
| Precautions |
|
Glaucoma. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Transient ocular burning or stinging, keratopathy, edema, irritation, keratitis sicca, hyperemia, increased intraocular pressure. |
| How Supplied |
|
Soln—7.5mL |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
